Meetings & Events

Akili

October 19, 2020 | 7:00 PM–8:30 PM

EndeavorRx is the first FDA-cleared treatment for inattention in children with ADHD, delivered through a video game experience. Learn about Akili Interactive, the company that developed EndeavorRx, and the scientific principles behind the treatment. This presentation will also cover the clinical studies in children with ADHD, who used EndeavorRx and how EndeavorRx is now available for interested families. Jacqueline Lutz, PhD, is a Scientist at Akili Interactive. Prior to Akili Interactive, Dr. Lutz studied Neuropsychology at the University of Zurich and worked as a research assistant and clinical psychologist at the Psychiatric University Hospital in Zurich, Switzerland. Dr. Lutz was a Honorary Fellow at the Center for Health Minds, University of Wisconsin - Madison. Her postdoctoral work in Massachusetts General Hospital/Harvard Medical School focused on the science of behavior change and meditation, and was the recipient of a Mind and Life Varela Grant. Dr. Lutz's interest lies in how interventions, such as meditation and games, can improve cognitive health.

Contact: Shirelle Pearson

Phone: 2423263

CHADD AFFILIATE: CHADD of Nassau County

Contact: Shirelle F. Pearson;  Email: nassau-county@chadd.net;  Phone: 516-242-3263

CHADD NATIONAL

Cover-2020-ADHD-Conf.jpg

2020 Virtual International Conference on ADHD

November 5-7

CHADD-180.png

CHADD AFFILIATE: CHADD of Nassau County

CHADD National

4221 Forbes Blvd, Suite 270
Lanham, MD 20706

Email: customer_service@chadd.org
Tel: 301-306-7070
Fax: 301-306-7090

BIA_seal_150x250.png
facebook-25.png
twitter-25.png
youtube-25.png
glyph-logo_May2016.png
badgeRGB-244px.png
linkedIn-25.png

Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD)
CHADD does not endorse products, services, publications, medications, or treatments, including those advertised in any CHADD publications, webinars or podcasts.

© 2020 CHADD | https://chadd.org